Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil

The effectiveness of inactivated vaccines (VE) against symptomatic and severe COVID-19 caused by omicron is unknown. We conducted a nationwide, test-negative, case-control study to estimate VE for homologous and heterologous (BNT162b2) booster doses in adults who received two doses of CoronaVac in B...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranzani, Otavio T., Hitchings, Matt D. T., de Melo, Rosana Leite, de França, Giovanny V. A., Fernandes, Cássia de Fátima R., Lind, Margaret L., Torres, Mario Sergio Scaramuzzini, Tsuha, Daniel Henrique, David, Leticia C. S., Said, Rodrigo F. C., Almiron, Maria, de Oliveira, Roberto D., Cummings, Derek A. T., Dean, Natalie E., Andrews, Jason R., Ko, Albert I., Croda, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537178/
https://www.ncbi.nlm.nih.gov/pubmed/36202800
http://dx.doi.org/10.1038/s41467-022-33169-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537178/
https://www.ncbi.nlm.nih.gov/pubmed/36202800
http://dx.doi.org/10.1038/s41467-022-33169-0

Ejemplares similares